A new technology presented in 2017 to treat the number one killer of hospital patients is reminiscent of the research revealed at the Albert Einstein College of Medicine back in 1991. Sepsis, a severe infection that spirals from blood poisoning, is a growing problem. Early diagnosis and quick treatment is needed in order to stem the death rate from the condition.
The new technology involves a dialysis type procedure to clean the blood infection using magnetic particles to bind the bacteria. This is reminiscent of another technology based on a patent that was filed in 1993 by the doctors who discovered that microcurrents—a mild electric current flow—rendered “the bacteria, virus, parasites and/or fungus ineffective to infect or affect normally healthy cells while maintaining the biological usefulness of the blood or other fluids.” The patent suggested a dialysis procedure or the implanting of a small battery in an artery.
The Albert Einstein College of Medicine research was basically buried but led to Dr. Robert C. (Bob) Beck, D.Sc. developing a system that keeps the blood in the body while being treated. Two parts of the Beck Protocol—micropulsing or blood electrification and magnetic pulsing—allow blood and body fluids to remain in the body. The protocol has not attracted medical research to treat sepsis.
For details of the new technology, check: